Look behind the lecture: should age be accounted for in HTA decision-making?
In this feature, following participating in an Issue Panel at the International Society for Pharmacoeconomics and Outcomes Research’s 2021 virtual annual meeting (Virtual ISPOR 2021; 17–20 May), Vivian Reckers-Droog (Erasmus School of Health Policy and Management, Rotterdam, The Netherlands) presents an overview of the controversy surrounding accounting for age-related societal preferences in health technology assessment (HTA) decision-making. Please could you introduce yourself, your organization(s) and provide a brief summary of your career to date? My name is Vivian Reckers-Droog and I am an Assistant Professor of Equity Considerations within the Department of Health Economics at the Erasmus School of Health...